Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice.

Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...

Patients in the study with advanced bladder cancer had less risk of cancer progressing or returning when treated with ...

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...

Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms ...

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...

A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the ...

The trial showed a 'clinically meaningful' and 'statistically significant' improvement when treated with therapy plus BCG, ...

The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study ...

The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.

Common symptoms like blood in urine or frequent urination should prompt a visit to a urologist. Early evaluation is crucial for effective bladder cancer management. Consult a urologist promptly for ...